Vera Therapeutics (VERA) PT Raised to $60 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $31.97 +4.10%
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on Vera Therapeutics (NASDAQ: VERA) to $60.00 (from $39.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
- Matador (MTDR) PT Raised to $66 at Truist Securities
- Nomad Foods Ltd (NOMD) PT Raised to $15 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
